Background Renal denervation (RDN) has emerged as a guideline-recommended therapeutic option in hypertension management with several high-quality, randomised, placebo-controlled trials demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback